1. Home
  2. TVTX vs INDB Comparison

TVTX vs INDB Comparison

Compare TVTX & INDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • INDB
  • Stock Information
  • Founded
  • TVTX 2008
  • INDB 1907
  • Country
  • TVTX United States
  • INDB United States
  • Employees
  • TVTX N/A
  • INDB N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • INDB Major Banks
  • Sector
  • TVTX Health Care
  • INDB Finance
  • Exchange
  • TVTX Nasdaq
  • INDB Nasdaq
  • Market Cap
  • TVTX 3.1B
  • INDB 3.5B
  • IPO Year
  • TVTX N/A
  • INDB N/A
  • Fundamental
  • Price
  • TVTX $35.18
  • INDB $66.37
  • Analyst Decision
  • TVTX Strong Buy
  • INDB Buy
  • Analyst Count
  • TVTX 15
  • INDB 4
  • Target Price
  • TVTX $37.21
  • INDB $74.00
  • AVG Volume (30 Days)
  • TVTX 2.1M
  • INDB 266.2K
  • Earning Date
  • TVTX 10-30-2025
  • INDB 10-16-2025
  • Dividend Yield
  • TVTX N/A
  • INDB 3.55%
  • EPS Growth
  • TVTX N/A
  • INDB N/A
  • EPS
  • TVTX N/A
  • INDB 4.05
  • Revenue
  • TVTX $435,826,000.00
  • INDB $712,224,000.00
  • Revenue This Year
  • TVTX $108.68
  • INDB $33.63
  • Revenue Next Year
  • TVTX $40.23
  • INDB $20.70
  • P/E Ratio
  • TVTX N/A
  • INDB $16.42
  • Revenue Growth
  • TVTX 114.22
  • INDB 8.60
  • 52 Week Low
  • TVTX $12.91
  • INDB $52.15
  • 52 Week High
  • TVTX $36.76
  • INDB $77.23
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 66.12
  • INDB 40.60
  • Support Level
  • TVTX $33.05
  • INDB $69.38
  • Resistance Level
  • TVTX $36.76
  • INDB $71.34
  • Average True Range (ATR)
  • TVTX 1.95
  • INDB 2.02
  • MACD
  • TVTX -0.02
  • INDB -0.07
  • Stochastic Oscillator
  • TVTX 80.99
  • INDB 18.42

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About INDB Independent Bank Corp.

Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.

Share on Social Networks: